We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Advanced Endoscopy Platform Targets Challenging Upper GI Procedures

By LabMedica International staff writers
Posted on 13 May 2026

Fujifilm’s ELUXEO 8000 Endoscopic Imaging System, used with the EG-840TP ultra‑slim therapeutic gastroscope, was named “Best New Endoscopy Technology Solution” in the 10th annual MedTech Breakthrough Awards program. More...

Announced on May 7, 2026, the recognition marks the second consecutive year MedTech Breakthrough has honored a Fujifilm endoscopy platform. The system-scope combination was launched in 2025 to support clinicians performing advanced, noninvasive upper gastrointestinal procedures.

The ELUXEO 8000 is a single-unit processor and light source designed to enhance image quality, therapeutic capabilities, and workflow. In addition to established image‑enhancement light modes, the platform introduces a proprietary Amber‑Red Color Imaging (ACI) mode. ACI supports detection of bleeding sources and improves visualization of blood vessels and tissue layers in the submucosal space during Third Space Endoscopy (TSE), providing the ability to help reduce procedural risks such as internal bleeding or inadvertent muscle injury.

When paired with the EG-840TP gastroscope, the platform combines high‑performance imaging with a device engineered for difficult anatomy. The EG-840TP features a 7.9 mm outer diameter to navigate strictures and facilitate submucosal tunneling, along with enhanced angulation for access. A dedicated water‑jet helps maintain visualization during TSE, and complementary metal‑oxide‑semiconductor (CMOS) imaging technology supports advanced image clarity.

MedTech Breakthrough is an independent market intelligence organization recognizing top companies and products in global medical technology. This year’s program attracted more than 4,500 nominations from over 18 countries. In 2025, Fujifilm’s EN‑840T Double Balloon Enteroscopy scope received the same endoscopy category award.

“We’re thrilled to be recognized by MedTech once again with this Breakthrough Award. Interventional upper GI and Third Space Endoscopy procedures are noninvasive and lead to shorter hospital stays, quicker recoveries, and better outcomes—but they are very challenging for clinicians. Fujifilm’s ELUXEO 8000 system coupled with our EG-840TP ultra slim therapeutic gastroscope are tools designed to support these clinicians and help push the boundaries of emerging upper GI endoscopy techniques,” said Tai Fujita, Senior Vice President, Endoscopy Division, FUJIFILM Healthcare Americas Corporation.

“Fujifilm is elevating and advancing the field of third space therapeutic endoscopy with their uniquely innovative dual technologies,” said Steve Johansson, managing director, MedTech Breakthrough. “We are delighted to recognize this endoscopy leader for the second consecutive year with a MedTech Breakthrough Award.”
 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Pipette Calibration System
Artel PCS®
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.